An experimental new drug by Pfizer has been proven to eliminate progression of an incurable form of breast cancer for over two years, according to new research presented at the San Antonio Breast Cancer Symposium. Patients were given the medicine, called PD 0332991, with Novartis (NOVN) AG's Femara. The findings reveal no tumor advancement for a median of 26.1 months, compared with 7...
More...